Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion (original) (raw)

• Martin, J.B. & Gusella, J.F. Huntington's disease: pathogenesis and management. N. Engl. J. Med. 315, 1267–1276 (1986).
  Article CAS PubMed Google Scholar
• Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neuml. 44, 559–577 (1985).
  Article CAS Google Scholar
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72, 971–983 (1993).
  Article Google Scholar
• McNeil, S.M. et al. Reduced penetrance of the Huntington's disease mutation. Hum. Mol. Genet. 6, 775–779 (1997).
  Article CAS PubMed Google Scholar
• Rubinsztein, D.C. et al. Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36–39 repeats. Am. J. Hum. Genet. 59, 16–22 (1996).
  CAS PubMed PubMed Central Google Scholar
• Gusella, J.F., Persichetti, F. & MacDonald, M.E. The genetic defect causing Huntington's disease: repeated in other contexts. Mol. Med. 3, 238–246 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ide, K. et al. Abnormal gene product identified in Huntington's disease lymphocytes and brain. Biochem. Biophys. Res. Commun. 209, 1119–1125 (1995).
  Article CAS PubMed Google Scholar
• Trottier, Y. et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104–110 (1995).
  Article CAS PubMed Google Scholar
• Jou, Y.S. & Myers, R.M. Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465–469 (1995).
  Article CAS PubMed Google Scholar
• Sharp, A.H. et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14, 1065–1074 (1995).
  Article CAS PubMed Google Scholar
• DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 14, 1075–1081 (1995).
  Article CAS PubMed Google Scholar
• Gutekunst, C.-A. et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl. Acad. Sci. USA. 92, 8710–8714 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Persichetti, F. et al. Normal and expanded Huntington's disease alleles produce distinguishable proteins due to translation across the CAG repeat. Mol. Med. 1, 374–383 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Trottier, Y. et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 378, 403–406 (1995).
  Article CAS PubMed Google Scholar
• Persichetti, F. et al. Huntington's disease CAG trinucleotide repeats in neuropathologically confirmed post-mortem brains. Neurobiol. Dis. 1, 159–166 (1995).
  Article Google Scholar
• Li, X.J. et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature. 378, 398–402 (1995).
  Article CAS PubMed Google Scholar
• Bao, J. et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc. Natl. Acad. Sci. USA. 93, 5037–5042 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Burke, J.R. et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347–350 (1996).
  Article CAS PubMed Google Scholar
• Kalchman, M.A. et al. HIP1, a human homologue of S cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet. 16, 44–53 (1997).
  Article CAS PubMed Google Scholar
• Wanker, E.E. et al. HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487–495 (1997).
  Article CAS PubMed Google Scholar
• Ambrose, C.M. et al. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somatic Cell Mol. Genet. 20, 27–38 (1994).
  Article CAS Google Scholar
• Duyao, M.P. et al. Homozygous inactivation of the mouse Hdh gene does not produce a Huntington's disease-like phenotype. Science. 269, 407–410 (1995).
  Article CAS PubMed Google Scholar
• Zeitlin, S. et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet. 11, 155–162 (1995).
  Article CAS PubMed Google Scholar
• Myers, R.H. et al. Homozygote for Huntington's disease. Am. J. Hum. Genet. 45, 615–618 (1989).
  CAS PubMed PubMed Central Google Scholar
• Wexler, N.S. et al. Homozygotes for Huntington's disease. Nature. 326, 194–197 (1987).
  Article CAS PubMed Google Scholar
• Nasir, J. et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 81, 811–823 (1995).
  Article CAS PubMed Google Scholar
• MacDonald, M.E. & Gusella, J.F. Huntington's disease: translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638–650 (1996).
  Article CAS PubMed Google Scholar
• Barnes, G.T. et al. Mouse Huntington's disease gene homolog (Hdh). Somat. Cell Mol. Genet. 20, 87–97 (1994).
  Article CAS PubMed Google Scholar
• Lin, B. et al. Sequence of the murine Huntington disease gene: evidence for conservation, alternate splicing and polymorphism in a triplet (CCG) repeat [published erratum appears in Hum. Mol. Genet. 3, 530 (1994)]. Hum. Mol. Genet. 3, 85–92 (1994).
  Google Scholar
• MacDonald, M.E. et al. Targeted inactivation of the mouse Huntington disease homologue Hdh . Cold Spring Harbor Symp Quant. Biol. 61, 627–638 (1996).
  Article CAS PubMed Google Scholar
• Lin, B. et al. Structural analysis of the 5′ region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms. Genomics. 25, 707–715 (1995).
  Article CAS PubMed Google Scholar
• Stumpo, D.J. et al. MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. USA. 92, 944–948 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, M. et al. Neural tube defects and abnormal brain development in F52-deficient mice. Proc. Natl. Acad. Sci. USA. 93, 2110–2115 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Hui, C.-C. & Joyner,, A.L A mouse model of Greig cephalo-polysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the GH3 gene. Nature Genet. 3, 241–246 (1993).
  Article CAS PubMed Google Scholar
• Shah, V. et al. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10, 175–180 (1995).
  Article Google Scholar
• Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384, 368–372 (1996).
  Article CAS PubMed Google Scholar
• Gusella, J.F., Persichetti, F. & MacDonald, M.E. The genetic defect causing Huntington's disease: repeated in other contexts. Mol. Med. 3, 238–246 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Bingham, P.M. et al. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice [published erratum appears in. _Nature Genet._ **9**, 191–196 (1995).
  Article CAS PubMed Google Scholar
• Goldberg, Y.P. et al. Absence of disease phenotype and intergenerational stability of the CAG repeat in transgenic mice expressing the human Huntington disease transcript. Hum. Mol. Genet. 5, 177–185 (1996).
  Article CAS PubMed Google Scholar
• Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo . Nature Genet. 13, 196–202 (1996).
  Article CAS PubMed Google Scholar
• Burright, E.N. et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82, 937–948 (1995).
  Article CAS PubMed Google Scholar
• Mangiarini, L.E. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87, 493–506 (1996).
  Article CAS PubMed Google Scholar
• Hanks, M. et al. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2 . Science. 269, 679–682 (1995).
  Article CAS PubMed Google Scholar
• Warner, J.P., Barren, L.H. & Brock, D.J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol. Cell. Probes. 7, 235–239 (1993).
  Article CAS PubMed Google Scholar
• Nagy, A. et al. Derivation of completely cell culture–derived mice from early-passage embryonic stem cells. Proc Natl. Acad. Sci. USA. 90, 8424–8428 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Wurst, W. & Joyner, A.L. Production of targeted embryonic stem cell clones in Gene Targeting: A Practical Approach (ed. A.L. Joyner) 33–62 (Oxford University Press, Oxford, UK, 1993).
  Google Scholar
• Nagy, A. & Rossant, J. Production of completely ES cell-derived fetuses. in Gene Targeting: A Practical Approach (ed. A.L. Joyner) 147–180 (Oxford University Press, Oxford, UK, 1993).
• Miller, M.W. & Nowakowski, R.S. Use of bromodeoxyuridine-immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res. 457, 44–52 (1988).
  Article CAS PubMed Google Scholar